Top compounds associated with response to RALYL


Feature Type Standardized
Nominal ANOVA
mRNA ML334 diastereomer CTRPv2 pan-cancer AAC -0.00056 1
mRNA XAV-939 GDSC1000 pan-cancer AAC -0.00028 1
mRNA Irinotecan FIMM pan-cancer AAC 0.001 1
mRNA Sorafenib GDSC1000 pan-cancer AAC 0.00016 1
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC -8.2e-05 1
mRNA clofarabine CTRPv2 pan-cancer AAC -5.3e-05 1
Download CSV